Home > Cannabis and Cannabinoids; is there (yet) a case for their use in therapeutics?

Quinn, Brendan (2012) Cannabis and Cannabinoids; is there (yet) a case for their use in therapeutics? Irish Pharmacy Union Review , (November) , pp. 25-26.

URL: http://ipu.ie/images/stories/publications/IPU%20Re...

The Department of Health has said it hopes to bring forward legislative proposals later this year, or early in 2013, to allow cannabis-based medicinal products to be prescribed in Ireland. The Irish Medicines Board has received a market authorisation request from GW Pharma, the makers of Sativex, and the agency has recommended the approval of the product for the Irish market based on an analysis of its quality, safety and efficacy. However, a change in the law to the Misuse of Drugs Act would be needed to allow the drug to be prescribed, as cannabis-based medicines are currently Schedule 1 controlled substances. In this article, Brendan Quinn, Community Pharmacist in Gort, discusses the issue.

 

Item Type:Article
Date:2012
Page Range:pp. 25-26
Publisher:Irish Pharmacy Union
Number:November
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Substances > Cannabis product (synthetic cannabinoids)
VA Geographic area > Europe > Ireland
L Social psychology and related concepts > Legal availability or accessibility

Repository Staff Only: item control page